Glutamine PET Imaging of Colorectal Cancer
Phase of Trial: Phase 0
Latest Information Update: 19 Dec 2018
At a glance
- Drugs BAY 949392 (Primary) ; Glutamine
- Indications Colorectal cancer
- Focus Diagnostic use; Pharmacokinetics
- 10 Dec 2018 Primary endpoints changed also trial focus changed to Pharmacokinetics (PK) and Diagnostic Use (DU).
- 31 Aug 2018 Biomarkers information updated
- 18 Oct 2017 Status changed from not yet recruiting to recruiting.